Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - TOTAL EQUITY
Total Equity MBRX - Moleculin Biotech, Inc.
26.1 M
LAST VALUE
-42.55%
2 YEAR CAGR
12.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR